Adma Biologics, Inc.
ADMA
Revenue
121.98M
▲7.18M▲6.26%
3 Months ChangeAssets
558.38M
▲47.81M▲9.36%
3 Months ChangeLiabilities
160.06M
▲22.91M▲16.70%
3 Months ChangeFree Cash Flow
-24.38M
▼-19.81M▼-433.98%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 8-K
ID: 0001140361-24-044808
2024-10-10
Form 8-K
ID: 0001140361-24-043250
2024-10-09
Form 8-K
ID: 0001140361-24-043222
2024-08-14
Form 8-K
ID: 0001140361-24-037184
2024-08-08
Form 10-Q
ID: 0001140361-24-036432
2024-08-08
Form 8-K
ID: 0001140361-24-036399
2024-07-26
Form 8-K
ID: 0001140361-24-034440
2024-06-28
Form 8-K
ID: 0001140361-24-031778
2024-06-04
Form 8-K
ID: 0001140361-24-028800
2024-05-17
Form 8-K
ID: 0001140361-24-026601